LCGC Awards
LCGC has announced the winners of the 4th Annual Emerging Leader and Lifetime Achievement in Chromatography Awards.
LCGC has announced the winners of the 4th Annual Emerging Leader and Lifetime Achievement in Chromatography Awards.
The Emerging Leader award recognizes the achievements and aspirations of a talented young scientific or technical professional who has made strides early in their career towards the advancement of chromatographic applications and techniques. This year’s winner is Dwight Stoll who is currently an assistant professor at Gustavus Adolphus College, Saint Peter, Minnesota, USA. Dr Stoll developed fast, comprehensive two‑dimensional high performance liquid chromatography (c2D-HPLC) as an analytical tool capable of quickly separating and quantifying hundreds of chemical constituents of complex mixtures.
The Lifetime Achievement award honours a seasoned professional for a lifetime of contributions to the advancement of chromatographic techniques and applications. This year’s winner is James W. Jorgenson the William Rand Kenan, Jr. Distinguished Professor in the Department of Chemistry at the University of North Carolina, USA. Dr Jorgenson has authored or co-authored more than 100 journal articles, and has served on the editorial boards of seven different journals. His research concerns the use of capillary electrophoresis, capillary liquid chromatography and mass spectroscopy to solve problems in complex mixture analysis. His work on the use of ultra-high pressures in liquid chromatography is widely regarded as critical to the success of what is now known as UHPLC.
This story originally appeared in The Column. Click here to view that issue.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
